ChemicalBook > CAS DataBase List > N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine

N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine

Product Name
N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
CAS No.
83461-56-7
Chemical Name
N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
Synonyms
MIFAMURTIDE;MTP-PE;CGP 19835;MLV 19835;MTP-cephalin;L-MTP-PE. MTP-PE;CGP 19835A Lipid;Medchemexpress(MTP-PE);Mifamurtide (CGP-19835);muramyl tripeptide phosphatidylethanolamine
CBNumber
CB11249151
Molecular Formula
C59H109N6O19P
Formula Weight
1237.52
MOL File
83461-56-7.mol
More
Less

N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine Property

Density 
1.152
storage temp. 
-20°C
solubility 
water: soluble2mg/mL, clear (warmed)
form 
powder
pka
1.39±0.50(Predicted)
color 
white to beige
InChIKey
ZVLWUMPAHCEZAW-HYGHKABSNA-N
CAS DataBase Reference
83461-56-7
More
Less

Safety

WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TRC
Product number
M343940
Product name
Mifamurtide
Packaging
25mg
Price
$13390
Updated
2021/12/16
Biosynth Carbosynth
Product number
FM36618
Product name
Mifamurtide
Packaging
0.5mg
Price
$800
Updated
2021/12/16
Biosynth Carbosynth
Product number
FM36618
Product name
Mifamurtide
Packaging
1mg
Price
$1000
Updated
2021/12/16
Biosynth Carbosynth
Product number
FM36618
Product name
Mifamurtide
Packaging
2mg
Price
$1200
Updated
2021/12/16
Biosynth Carbosynth
Product number
FM36618
Product name
Mifamurtide
Packaging
5mg
Price
$1500
Updated
2021/12/16
More
Less

N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine Chemical Properties,Usage,Production

Uses

Osteosarcoma.

Uses

Mifamurtide may be used in immunological and cancer-related cell signaling studies.

Biochem/physiol Actions

Mifamurtide is an immunomodulator and regulates the activation of monocytes and macrophages. Mifamurtide upregulates the secretion of pro-inflammatory cytokines such as TNF-α, IL-1, IL-8, nitric oxide and prostaglandins E2 and D2. It has anti-tumor effects in children and young adults with high-grade osteosarcoma.

Mechanism of action

Being a phospholipid, mifamurtide accumulates in the lipid bilayer of the liposomes upon infusion. After application of the liposomal infusion, the drug is cleared from the plasma within minutes. However, it is concentrated in lung, liver, spleen, nasopharynx and thyroid, and the terminal half-life is 18 hours, which is longer than the natural substance.

Clinical Use

Mifamurtide is an anticancer agent for the treatment of osteosarcoma, the most common primary malignancy of bone tissue mainly affecting children and adolescents. The drug was invented by Ciba-Geigy (now Novartis) in the early 1980s and the agent was subsequently licensed to Jenner Biotherapies in the 1990s. IDM Pharma bought the rights to the drug from Jenner in April 2003.In March 2009, mifamurtide was approved in the 27 European Union member states plus Iceland, Liechtenstein and Norway via a centralized marketing authorization. After the approval, IDM Pharma was acquired by Takeda, which began launching mifamurtide, as Mepact ®, in February 2010. Mifamurtide, a fully synthetic lipophilic derivative of muramyl dipeptide (MDP), is muramyl tripeptide phosphatidylethanolamine (MTP-PE), which is formulated as a liposomal infusion.

Synthesis

Two synthetic routes have been reported, and the scheme describes the more process-amenable route. Commercially available 1,2-dipalmitoyl-snglycero- 3-phosphoethanolamine (110) was coupled with N-Boc-L-alanine (111) by means of Nhydroxysuccinimide (112), DCC in DMF to give amide 113, which was followed by hydrogenolysis of the CBZ group to give the corresponding L-alanyl-phosphoric acid 114. Next, commercially available N-acetylmuramoyl-L-alanyl-D-isoglutamine (115) was subjected to hydroxybenzotriazole (HOBT) and DIC in DMF to provide the corresponding succinimide ester 116 which was condensed with compound 114 to provide mifamurtide (IX). No yields were provided for these transformations.

Drug interactions

Potentially hazardous interactions with other drugs
Analgesics: avoid with high dose NSAIDs.
Ciclosporin: avoid concomitant use.
Corticosteroids: avoid concomitant use.
Tacrolimus: avoid concomitant use.

Metabolism

The cells of the reticuloendothelial system clear mifamurtide liposomes by phagocytosis.

N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine Suppliers

LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1493
Advantage
55
China Kouting Group Limited
Tel
+86 (21) 5811-6473 5811-6475
Fax
+86 (21) 6129-4103
Email
sales@koutingchina.com
Country
China
ProdList
496
Advantage
60
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Fax
051085625359
Email
sales@reading-chemicals.com
Country
China
ProdList
15178
Advantage
58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66113011 18112977050
Email
cb6@aikonchem.com
Country
China
ProdList
16684
Advantage
50
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Fax
025-68650336
Email
info@adooq.cn
Country
China
ProdList
2990
Advantage
60
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
Fax
+86 (21) 6129-4103
Country
China
ProdList
9756
Advantage
58
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51456
Advantage
80
Creative Peptides
Tel
Email
info@creative-peptides.com
Country
United States
ProdList
6083
Advantage
56
More
Less

View Lastest Price from N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine manufacturers

Shandong Huizhihan Supply Chain Co., Ltd
Product
Mifamurtide 83461-56-7
Price
US $0.00-0.00/box
Min. Order
1box
Purity
99%
Supply Ability
2000
Release date
2024-10-29
Shandong Huizhihan Supply Chain Co., Ltd
Product
Medchemexpress(MTP-PE) 83461-56-7
Price
US $0.00-0.00/BOX
Min. Order
1BOX
Purity
99%
Supply Ability
20T
Release date
2024-11-12
Henan Bao Enluo International TradeCo.,LTD
Product
N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine 83461-56-7
Price
US $45.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
20tons
Release date
2023-05-12

83461-56-7, N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamineRelated Search:


  • N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
  • muramyl tripeptide phosphatidylethanolamine
  • MIFAMURTIDE
  • N-(N-Acetylmuramoyl)-L-alanyl-D-alpha-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-L-alaninamide
  • CGP 19835
  • L-MTP-PE. MTP-PE
  • MLV 19835
  • MTP-PE
  • MTP-cephalin
  • N-(N-Acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-L-alaninamide
  • Mifamurtide (CGP-19835)
  • CGP 19835A Lipid
  • CGP 19835A LIPID;MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE LIPOSOME;L-MTP-PE;CGP-19835;MTP-PE;MTP-CEPHALIN;CGP19835;L-MTP-PE;MLV19835
  • muramyl tripeptide phosphatidylethanolamine liposome
  • L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-
  • N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine USP/EP/BP
  • Medchemexpress(MTP-PE)
  • 83461-56-7